{"filing":{"accession_number":"0001213900-26-072598","cik":"0001835615","ticker":"MHUAF","company_name":"Meihua International Medical Technologies Co., Ltd.","form":"6-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ea0296151-6k_meihua.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1835615/000121390026072598/ea0296151-6k_meihua.htm"},"events":[{"id":14203,"run_id":12634,"accession_number":"0001213900-26-072598","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The filing discloses Meihua's entry into a new Software-as-a-Service (SaaS) business segment through its U.S. subsidiary, Meihua Future, launched in July 2025. The company provides detailed strategic plans for medical registration and healthcare SaaS systems across North America, Hong Kong, and Southeast Asia, with cumulative signed contracts of USD 16.125 million as of month-end. This represents a material strategic business pivot from the company's traditional medical device manufacturing operations, warranting classification as a significant operational/strategic initiative that would affect a reasonable investor's assessment of the registrant's business direction and growth prospects.","company_name":"Meihua International Medical Technologies Co., Ltd.","ticker":"MHUAF","filing_date":"2026-06-26","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":11567,"accession_number":"0001213900-26-072598","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The filing discloses Meihua's entry into a new Software-as-a-Service (SaaS) business segment through its U.S. subsidiary, Meihua Future, launched in July 2025. The company provides detailed strategic plans for medical registration and healthcare SaaS systems across North America, Hong Kong, and Southeast Asia, with cumulative signed contracts of USD 16.125 million as of month-end. This represents a material strategic business pivot from the company's traditional medical device manufacturing operations, warranting classification as a significant operational/strategic initiative that would affect a reasonable investor's assessment of the registrant's business direction and growth prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:05:58.181275+00:00","company_name":"Meihua International Medical Technologies Co., Ltd.","ticker":"MHUAF","filing_date":"2026-06-26"}]}